Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)

Brief summary (registry, in English)

This registry is designed to collect long-term data and support ongoing post-market surveillance of real-world data for the Endogenex System.

What you commit to

• Study type: Observational
• Planned participants: 500
• From 11 Mar 2026 to the primary completion date, May 2032
• 4 sites in 2 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.